NL-OMON56768尚未招募不适用
Circulating cell free DNA: the fingerprint of the Placenta - FIERCE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64(—)
入选标准
- •- Pregnant women >= 18 years and <= 45 years who are willing to participate.
- •- Sufficient understanding of Dutch in speaking and reading.
- •- Willingness to give written informed consent.
- •- Singleton pregnancy.
- •- Blood drawing (venapunction) planned for clinical purposes.
- •Two patient groups are eligible:
- •- Healthy pregnant women with an uncomplicated pregnancy (10 controls).
- •- Healthy pregnant women with a premature delivery (between 24 and <37 weeks)
- •clinically with suspicion of inflammation (20 cases).
- •Placentas from the pathology archive that can be used for research for a
- •baseline quality check:
- •- 10 placentas from an uncomplicated pregnancy (controls)
- •- 10 placentas with a premature delivery (between 24 and <37 weeks) clinically
- •with suspicion of inflammation (cases)
排除标准
- •Multiple pregnancy.
- •- Gastro-intestinal diseases, heart diseases, liver, pancreas and kidney
- •- Pre-existent diabetes mellitus.
- •- Unable or unwilling to give informed consent.
- •- Fetus with a known congenital/chromosomal abnormality.
研究者
相似试验
尚未招募
不适用
Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapymalignant tumorJPRN-UMIN000003715Yokohama City University, School of Medicine30
招募中
4 期
The use of donor-derived circulating cell free DNA for early detection of rejection and to modulate immunosuppression following liver transplantation: A randomized controlled trial.CTRI/2023/10/059270Amrita institute of medical sciences and research
招募中
不适用
ongitudinal characterization of circulating DNA in serum of patients after allogenic bone augmentatioPatients in need of bone augmentation prior dental implant placementDRKS00013010niversitätsklinikum Hamburg-EppendorfInstitut für Tumorbiologie35
尚未招募
不适用
Cell-free DNA as a new, minimally invasive and sensitive biomarker for early detection of allograft rejection after heart transplantatioNL-OMON45738Erasmus MC, Universitair Medisch Centrum Rotterdam60
已完成
不适用
forecasting capacity of Circulating Free DNA to assess treatment results in Patients with Oral CancerCTRI/2019/03/018136RMLIMS30
